Skip to main content

Diabetes

  • Diabetes stakeholders discuss how healthcare-reform law affects patients

    NEW YORK — Healthcare reform has remained a major subject of debate since President Barack Obama signed the Patient Protection and Affordable Care Act last March, but what the law means for diabetes care was the particular focus of a conference call with diabetes stakeholders Tuesday.

  • Study: Intensive diabetes education programs could improve blood-sugar control

    NEW YORK — A diabetes education program developed by Johns Hopkins researchers significantly improved long-term blood-sugar control among patients.

  • SmartDiabetes products arrive in Florida Walgreens stores

    TITUSVILLE, Fla. — Infopia America last week announced that its new SmartDiabetes product line has launched in 284 Walgreens drug stores in central and northeast Florida. The central Florida Walgreens region includes stores in Jacksonville, Orlando, Lakeland, Daytona Beach and Melbourne.

  • Express Scripts: Aligning patient behavior, intentions could save money for healthcare system

    ST. LOUIS — The road to waste reduction is paved with good intentions.

    That’s the conclusion of pharmacy benefit manager Express Script’s "2010 Drug Trend Report," which found that 33% of annual pharmacy-related waste can be eliminated by encouraging patients to improve common behaviors linked to their prescription drugs by harnessing their good intentions.

  • Study: POS electronic safety check can reduce heart attack risk among diabetes patients

    ST. PAUL, Minn. — A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

  • Regeneron, Bayer commence phase-3 trial for diabetic macular edema treatment

    TARRYTOWN, N.Y. and BERLIN — Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

    The drug makers said that it would evaluate the efficacy of VEGF Trap-Eye (aflibercept ophthalmic solution) in the treatment of diabetic macular edema, a prevalent cause of vision loss among diabetes patients, after promising results from its previous clinical trial.

  • New app offers diabetics meal planning tips

    WALTHAM, Mass. — Quantia has partnered with dietitian and diabetes educator Hope Warshaw to develop EatSmart, a mobile diabetes application.

    EatSmart, currently a free download available for the iPhone, Android, smartphones, tablets and the Web, is an app that provides those affected by or at risk for Type 2 diabetes with simple meal planning tips and tricks.

  • Walk with Walgreens kicks off in New York's Times Square

    NEW YORK — Walgreens on Wednesday morning launched a national health initiative, Walk with Walgreens, here at its flagship store in Times Square.

    The new initiative was created to lead to the prevention and early detection of leading diseases, including cancer, heart disease and diabetes, the pharmacy operator stated.

X
This ad will auto-close in 10 seconds